Core Insights - IBA has signed a contract with YAS Healthcare to install a ProteusONE compact proton therapy solution in Dubai, marking a significant advancement in cancer treatment in the UAE [1][2][4] - This installation will establish the first operational proton therapy center in the Gulf Cooperation Council (GCC) region, with patient treatments expected to commence in 2029 [2][4] - The contract includes the latest generation of proton therapy systems and a multi-year operation and maintenance agreement, with the typical price for such a system ranging between €35 million and €45 million [3][4] Company Overview - IBA is recognized as the world leader in particle accelerator technology and the leading provider of proton therapy solutions for cancer treatment [1][6] - The company is based in Louvain-la-Neuve, Belgium, and employs approximately 2,100 people globally, holding a B Corporation certification for social and environmental performance [6] - YAS Healthcare, a subsidiary of DAS Holding, is a prominent healthcare provider in Abu Dhabi, established in 2014, focusing on high-quality medical services [7]

Company Overview - IBA (Ion Beam Applications S.A.) is a global leader in particle accelerator technology, specializing in proton therapy, industrial sterilization, radiopharmaceuticals, and dosimetry [5][6] - The company is headquartered in Louvain-la-Neuve, Belgium, and employs approximately 2,100 people worldwide [5] - IBA is recognized as a certified B Corporation (B Corp), meeting high standards of verified social and environmental performance [5] Financial Information - The total capital of IBA is reported at EUR 42,502,318.54 [2] - The number of securities with voting rights is 30,282,218, which is the basis for calculating the 30% threshold under the takeover law [2] - The existing voting rights total 40,514,619, which serves as the denominator for calculating the quota of voting rights that may trigger notification requirements [2] Voting Rights and Regulations - IBA has introduced loyalty voting rights, which apply to registered shares held for at least two consecutive years [3] - The calculation method for loyalty voting rights is based on the LIFO (last in, first out) method [4] - There is a statutory ceiling that limits any shareholder's voting participation to a maximum of 35% of the total votes attached to shares with voting rights, equating to approximately 14,180,116.65 votes based on current figures [5]

Core Viewpoint - Concord Healthcare Group has made significant advancements in precise tumor diagnosis and treatment technology, particularly with the launch of its self-developed large language model (LLM) for proton therapy, which has been successfully implemented in Guangzhou Concord Cancer Hospital [1][2]. Company Overview - Concord Medical Services Holdings Limited is a healthcare provider specializing in comprehensive oncology services, including cancer diagnosis, treatment, education, and prevention, with a focus on improving the quality and accessibility of cancer care across China [4]. - The company operates a network of self-owned cancer hospitals and clinics, equipped with advanced technology such as proton therapy systems, and aims to provide multidisciplinary cancer care [4]. Technology and Innovation - The proton LLM developed by Concord Healthcare is the first of its kind in China, utilizing a robust tumor diagnosis and treatment technology system built on extensive data accumulated over the years, including nearly 10,000 high-quality radiotherapy cases [2]. - The model integrates data from Proton China and professional journal literature to enhance its training and effectiveness in patient treatment [2]. Market Position - Concord Healthcare serves both cancer patients directly through its own medical institutions and indirectly through third-party medical institutions by providing medical equipment, software, and related services [5]. - The company has established a widespread network of enterprise customers, primarily hospitals, offering integrated oncology-related services, including sales and installation of medical equipment, management, technical support, and operating leases [5].